スポンサーリンク
Gastroenterological Center, Yokohama City University Medical Center | 論文
- Use of accumulation images obtained by arterial-phase contrast-enhanced harmonic grayscale ultrasonography to evaluate tumor vessels in focal nodular hyperplasia and other hepatic tumors
- Osteoclast-like giant cell tumor of the pancreas
- Randomized, double-blind, placebo-controlled trial of bovine lactoferrin in patients with chronic hepatitis C
- Dose-response Trial of Lactoferrin in Patients with Chronic Hepatitis C
- Lactoferrin inhibits hepatitis B virus infection in cultured human hepatocytes
- Contrast-enhanced sonography of pancreatic carcinoma : correlations with pathological findings
- Diagnosis of Advanced Hepatocellular Carcinoma Using Contrast-Enhanced Harmonic Gray-Scale Imaging with Enhancement Agents (Levovist) : Correlation with Helical CT and US Angiography
- Spleen-Preserving Distal Pancreatectomy Combined with Distal Gastrectomy for Distal Pancreatic Lesion and Gastric Cancer : Report of a Case
- Primary malignant peripheral nerve-sheath tumor of the common bile duct
- Radiofrequency ablation in a pig liver model : effect of transcatheter arterial embolization on coagulation diameter and histologic characteristics
- Tandem Repeats of Lactoferrin-Derived Anti-Hepatitis C Virus Peptide Enhance Antiviral Activity in Cultured Human Hepatocytes
- Intrahepatic splenosis in a patient with chronic hepatitis C
- Long-Term Outcome After Hernia Repair with the Prolene Hernia System
- Hepatocellular carcinoma occurring in a young Crohn's disease patient
- Molecular targeted agents for gastric and gastroesophageal junction cancer
- Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with rheumatoid arthritis treated with methotrexate
- Novel Lens culinaris agglutinin-reactive fraction of α-fetoprotein : a biomarker of hepatocellular carcinoma recurrence in patients with low α-fetoprotein concentrations
- Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib